
Lisle Nabell
Program Director · University of Alabama Hospital
Credentials: · · ·
History
- 1990–1992
Medical Oncology
- 1987–1990
Internal Medicine

Research
Clinical Cancer Research · 2013 · 565 citations
Adult Cancer Pain, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2019 · 454 citations
Safety and Tumor Specificity of Cetuximab-IRDye800 for Surgical Navigation in Head and Neck Cancer
Clinical Cancer Research · 2015 · 390 citations

13 papers

11 papers

6 papers
- BM
5 papers

5 papers

5 papers

5 papers
- LG
5 papers
Clinical trials
- 2016–2019
Trial of Pembrolizumab for Advanced Penile Squamous Cell Carcinoma
Principal investigator · Terminated · Phase 2
University of Alabama at Birmingham
- 2015–2020
Trial Using Gilotrif for Advanced Penile Squamous Cell Carcinoma
Principal investigator · Terminated · Phase 2
University of Alabama at Birmingham
- 2015–2020
Study of Regorafenib for Urothelial Cancer Following Chemotherapy (UAB 1477)
Principal investigator · Completed · Phase 2
University of Alabama at Birmingham
- 2007–2022
Principal investigator · Completed · Phase 2
University of Alabama at Birmingham



